baber/WOPTO huggingface dataset:
Patent CA-2641374-A1 (CA)
Title: Non-linear, digital dailies
Inventor: BROWN TERRY SCOTT
IPC: H04N5/91
Filed: 2006-12-20
Abstract: A method includes storing at least a partial parallelization of at least two of an audio data processing, a video data processing, a synchronized processing of audio and video data from the audio data processing and video data processing, and output processing of the audio and video data from the synchronized processing.
Patent CA-2641464-A1 (CA)
Title: Automatic control line insertion tools and system
Inventor: CROW STEVE L
IPC: E21B43/08
Filed: 2007-02-01
Abstract: A system for inserting control lines to a control line receptacle at an alternate path structure includes an upper guide having a path structure engagement roller, a control line insertion wheel and a control line bypass space and further includes a lower guide separate from the upper guide and having a path structure engagement roller and a control line insertion wheel, the path structure engagement roller and control line insertion wheel being resiliently biased to a position calculated to cause control line insertion to the alternate flow path structure when in an engaged position.
Patent CA-2642843-A1 (CA)
Inventor: GRAVIER-PELLETIER CHRISTINE
IPC: C07H11/04
Filed: 2007-02-23
Abstract: Drug composition comprises an excipient and an active ingredient (T) e.g. mono (alpha -D-mannopyranosyl-1) phosphates, in a medium. Drug composition comprises an excipient and an active ingredient (T) e.g. mono (alpha -D-mannopyranosyl-1) phosphate of formula (I), (II) and/or (III), in a medium. R 11-R 14, R 21-R 24H or OH protecting group (preferably 2-6C aliphatic acyl); R, R1a : T 1, OB 1, O-CH(CH 3)-O-CO-(1-5C)alkyl, -O-CH(CH 3)-O-CO-O-(1-5C)alkyl or -O-CH 2-CH(OH)-CH 2OH, preferably OB 1, phenoxy, 1-naphtyloxy, benzyloxy, 1-naphtylmethoxy, -O-CH(Q)-O-CO-O-(1-5C) alkyl, -O-CH 2-CH(OH)-CH 2OH, OH protecting group, -NH-(CH 2) 4-CH(NH 2)COOH, -(p-O)-C 6H 4-CH 2-CH(NH 2)COOH, -O-CH 2-CH(NH 2)COOH or -O-CH(CH 3)- CH(NH 2)COOH, -NH-(CH 2) 3-CH-(NH 2)COOH or -NH-(CH 2) 2-CH(NH 2)COOH (where COOH and NH 2of each group is protected); T 16-10C aryloxy, (6-10C)aryl(1-5C)alkyleneoxy (both optionally substituted by T 2), -O-CH 2-CH(OH)-CH 2OH, OH protecting group (2-6C acyl), -X-A-CH(COOY 1)(NZ 2Z 3)- or -(Z 2)N-CH(Z 4)-COOY 1; T 21-5C alkyl, 1-5C alkoxy, halo, CF 3and/or NO 2; B 1optionally branched 2-21C ethylenic unsaturated hydrocarbon chain or 5-21C cycloaliphatic group, preferably farnesyloxy or geranyloxy group; X : -O-, -S- or -NZ 1; Y 12-5C alkyl; A, Z 41-5C alkylene, phenylene or phenylalkylene group; Z 1-Z 3H, 1-5C alkyl, or N protecting group; R1 : OH protecting group (2-6C acyl), 1-20C alkoxy, -O-CH(Q)-O-CO-alkyl, -O-CH(Q)-O-CO-O-(1-5C)alkyl, OB 1or T 1, phenoxy, 1-naphtyloxy, benzyloxy, 1-naphtylmethoxy, -O-CH(Q)-O-CO-O-(1-5C) alkyl, -O-CH 2-CH(OH)-CH 2OH, OH protecting group, -NH-(CH 2) 4-CH(NH 2)COOH, -(p-O)-C 6H 4-CH 2-CH(NH 2)COOH, -O-CH 2-CH(NH 2)COOH or -O-CH(CH 3)- CH(NH 2)COOH, -NH-(CH 2) 3-CH-(NH 2)COOH or -NH-(CH 2) 2-CH(NH 2)COOH (where COOH and NH 2of each group is protected); Q : H or CH 3; and R 31-R 34H or OH protecting group (preferably 3-6C aliphatic acyl). Independent claims are included for: (1) a mannosyl-1 phosphate derivative of formula (I), (II) and/or (III) useful as a drug; and (2) a process of preparing (I), (II) and (III) comprising reaction of a 1-bromo-mannopyranose of formula (IVa) with a monosilver phosphate of formula AgOP(=O)(R)(R1a), reaction of a 1-bromo-mannopyranose of formula (IVb) with the monosilver phosphate to form (II) and reaction of a 1-bromo-mannopyranose of formula (IVc) with a trisilverphosphate of formula P(=O)(AgO) 3, respectively. [Image] [Image] ACTIVITY : Metabolic. MECHANISM OF ACTION : None given.
Patent CA-2643136-A1 (CA)
Inventor: SMITH HAMILTON O
IPC: C12N1/00
Filed: 2006-12-22
Abstract: L'invention concerne l'introduction d'un génome dans une cellule ou un système de type cellule. Le génome introduit peut être naturel, synthétique avec ou sans automation, ou peut être un hybride de matériaux naturels et synthétiques. Le génome est sorti d'une cellule avec des dommages minimaux. Des matériaux tels que des protéines, des ARN, des polycations, des protéines de condensation de nucléotides ou des systèmes de traduction de gènes peuvent accompagner le génome. Le génome est installé dans une cellule naturelle ou dans un système synthétique de type cellule. Un système de type cellule ou une cellule synthétique résultant de la mise en AEuvre du procédé selon l'invention peut être conçu et utilisé pour obtenir des produits d'expression génique, tels que des protéines souhaitées. En permettant la synthèse de cellules ou de systèmes de type cellules comprenant une large variété de génomes, matériaux d'accompagnement et types de membranes, le procédé selon l'invention rend possible l'élargissement du domaine d'expérimentation et de biotechnologie disponible en utilisant les procédés de l'art antérieur.
Patent CA-2643322-A1 (CA)
Inventor: SINGH MANMOHAN
IPC: A61K9/16
Filed: 2007-02-24
Abstract: Immunogenic compositions are described herein which comprise microparticles that further comprise a biodegradable polymer. The microparticle compositions also comprise a cationic polysaccharide and an immunological species selected from an antigen, an immunological adjuvant and a combination thereof. Also described are methods of making such compositions and methods of administering such compositions. Methods of modulating the release rate of immunological species from microparticles are also described. These methods comprise varying the ratio of the cationic polysaccharide relative to the biodegradable polymer within the microparticles.
Patent CA-2645347-A1 (CA)
Inventor: TROUET ANDRE
IPC: A61K47/48
Filed: 2006-03-10
Abstract: This invention relates to the field of antibody-drug conjugates, and more particularly antibody-drug conjugates that are intended for the treatment and/or diagnosis of diseases such as tumors and/or inflammatory reactions.
Patent CA-2646348-A1 (CA)
Inventor: PAGE IAN
IPC: C11C3/02
Filed: 2007-02-27
Abstract: Physical refining processes using adsorbent particles are disclosed. The physical refining processes may be used in the production of biodiesel fuel precursors and biodiesel fuel.
Patent CA-2646725-A1 (CA)
Title: Flameproofed impact-resistance modified polycarbonate compositions
Inventor: ECKEL THOMAS
IPC: C08F283/12
Filed: 2007-03-09
Abstract: The present invention relates to impact-modified polycarbonate compositions comprising: A) from 40 to 78 parts by weight of branched aromatic polycarbonate and/or branched aromatic polyester carbonate, B) from 1 to 25 parts by weight of a graft polymer containing one or more graft bases (B.2) selected from the group of the silicone rubbers (B.2.1) and silicone acrylate rubbers (B.2.2), C) from 9 to 18 parts by weight of talc, D) from 11 to 20 parts by weight of a phosphorus-containing flameproofing agent, E) from 0.01 to 3 parts by weight of anti-dripping agent, and F) from 0 to 1.5 parts by weight of one or more thermoplastic vinyl (co)polymers F.1 and/or polyalkylene terephthalates F.2, which meet high requirements in terms of fireproofing, to a process for their preparation, to their use in the production of moulded bodies, and to thermoformed moulded bodies obtainable from the above-mentioned compositions.
Patent CA-2650820-A1 (CA)
Title: Use of base-modified deoxynucleoside triphosphates to improve nucleic acid detection
Inventor: KUTYAVIN IGOR
IPC: C07H19/10
Filed: 2007-04-30
Abstract: Aspects of the invention provide novel and surprisingly effective methods for the detection of nucleic acids, comprising nucleic acid amplification using base-modified deoxynucleoside 5'-triphosphates (dNTPs). Particular aspects relate to methods for enhancing hybridization properties of oligonucleotide primers and probes in assays detecting nucleic acids, comprise amplifying target DNAs in presence of base-modified duplex-stabilizing deoxyribonucleoside 5'-triphosphates to provide for modified target DNAs, and thereby considerably improving performance of the detection assays. The disclosed methods allow for increasing of the reaction temperature in PCR-based detection systems or, alternatively, reducing the length of the oligonucleotide primers and probes. Certain aspects relates to improvement of real time PCR assays, wherein nucleic acids of interest are detected as the reaction proceeds using fluorescent agents or oligonucleotide FRET probes.
Patent CA-2652046-A1 (CA)
Inventor: SPEICHER ASHLEY C
IPC: H04N21/488
Filed: 2007-06-25
Abstract: A media server (402) in a home entertainment network (416) coordinates with a media receiver (404) connected with the network (416) to provide a media presentation with a combined user interface on an attached display device (406). The media server (402) receives compositing information (436) from the media receiver (404) over the network (416) regarding the placement of UI components (434) generated by the media receiver (404). In response, the media server (402) may adjust the positioning of graphics, media control information, metadata, media presentation windows, and other UI components (410, 418, 420, 422) for presentation by the media receiver (404) such that the UI components (410) generated by the media server (402) do not interfere with the UI (432) generated by the media receiver (404) when rendered to the display device (406). Alternately, the media receiver (404) may adjust the position of UI components (432) such that the UI components (432) generated by the media receiver (404) do not interfere with the UI (410) generated by the media server (402) upon presentation.
Patent CA-2652333-A1 (CA)
Inventor: KOHARA MICHINORI
IPC: A61K45/00
Filed: 2007-05-16
Abstract: The inventors examined an anti-HCV effect of an SPT inhibitor and/or interferon using an HCV subgenomic replicon cell FLR3-1 or an HCV infected chimeric mouse. As a result, it was found that myriocin, an SPT inhibitor, or a compound represented by the formula (III) can be a novel therapeutic agent for HCV infection and that a higher HCV replication inhibitory effect can be obtained by concomitantly using the SPT inhibitor and interferon.
Patent CA-2652572-A1 (CA)
Inventor: CHALAYE SANDRINE
IPC: D21H21/44
Filed: 2007-05-18
Abstract: A process for manufacturing a material in sheet form, comprising at least one fibrous layer and a plurality of security and/or decorative elements, the process comprising at least one of the following steps: the security and/or decorative elements are sprayed onto one face of the fibrous layer, which is running along a predetermined direction, especially when the fibrous layer is still wet, so as to form at least one continuous pattern having at least one edge, approximately along the run direction, not entirely parallel to the run direction, and a pattern comprising a succession of separate zones, and security and/or decorative elements of at least two different types and/or having a variable concentration are sprayed onto one face of the fibrous layer, especially when it is still wet.
Patent CA-2653776-A1 (CA)
Inventor: BURI MATTHIAS
IPC: C09D7/80
Filed: 2007-06-05
Abstract: The present invention relates to composites, comprising inorganic and/or organic pigments and/or fillers in the form of microparticles, the surface of which is coated at least partially with finely divided nano-calcium carbonate with the help of binders based on copolymers comprising as monomers one or more diearboxylic acids and one or more monomers from the group of diamines, triamines, dialkanolamines or trialkanolamines, a method for producing such composites, aqueous slurries thereof and their use in papermaking or in the field of paint and plastic production and the use of the inventive binders for coating the micropartieles with iiano-calcium carbonate.
Patent CA-2654707-A1 (CA)
Inventor: ASRAR RASHID
IPC: A01M29/00
Filed: 2006-06-27
Abstract: An olfactory patch comprises a well (6) formed by a reservoir layer (2), the well sandwiched between a barrier layer (3) and a permeable layer (4). The permeable layer defines a pathway for olfactory fluid flow from the well (6) (A, Figure 1 ). The flow of the olfactory may be commenced by an initiator mechanism, and may control or terminate the flow of olfactory. The olfactory patch may utilise any olfactory fluid or combination of fluids within the same patch. The patch may utilise olfactory fluid which may provide any type of functionality from fragrance to drug delivery. The olfactory patch has applications in multiple environments and surfaces such as jewellery or fashion accessories or objects of therapeutic value. Micro electro-mechanical devices may be used within the patch system which utilise fuel cell technology to control olfactory flow or to provide any other functionality.
Patent CA-2656983-A1 (CA)
Title: Systems and methods for providing alternate line selection information on a mobile device
Inventor: OERTON KEVIN
IPC: H04M1/72469
Filed: 2009-03-04
Abstract: A system and method for providing a user interface that allows users to chan ge the active line on which an outgoing call may be placed. In example embodiments, upon detecting call screen interaction a line selection menu is displayed. The line selection menu contains a plurality of line identifiers, each line identifier uniquely identifying a corresponding one of the multiple communication lines accessible at the mobile device. A system and method is also presented for providing a call log for identifying call activity associated with a plurali ty of communication lines.
Patent CA-2656984-A1 (CA)
Title: Process for cell proliferation
Inventor: ESCAICH FERRER JOSEP
IPC: A61K35/12
Filed: 2007-07-31
Abstract: In vitro process for the proliferation or culture of conjunctive tissue cells selected from the group consisting of chondrocytes, osteoblasts, chondroprogenitor cells, osteoprogenitor cells, tenocytes and ligament cells comprising the step of contacting said cells with an aminosugar selected from the group consisting of mannosamine, N-acetylmannosamine, mannosamine salts and their mixtures. The present invention also relates to compositions which comprise the aminosugar in combination with the cells. These compositions are useful for the treatment of cartilage, bone, tendon and ligament lesions or defects, bone mass losses and osteochondral defects or lesions.
Patent CA-2657328-A1 (CA)
Title: Lung cancer diagnostic assay
Inventor: HIRSCHOWITZ EDWARD A
IPC: G01N33/564
Filed: 2007-07-06
Abstract: A diagnostic assay for determining presence of lung cancer in a patient depends, in part, on ascertaining the presence of an antibody associated with lung cancer using random polypeptides. The assay predicted lung cancer prior to evidence of radiographically detectable cancer tissue.
Patent CA-2658309-A1 (CA)
Title: Drive away axle assembly
Inventor: KORSON JAMES J
IPC: B60B27/00
Filed: 2009-03-13
Abstract: The drive away axle assembly comprises at least an axle shaft having a proximal end seated within an axle housing and a distal terminal flange and a hub having a distal end land and a sidewall. The distal terminal flange of the axle shaft has bores therein which align with threaded bores in the distal end land of the hub, and axle shaft/hub connectors engage through the bores to removably connect the hub to the axle shaft.  Further, an axle shaft retaining bolt extends through the sidewall of the hub for engagement with the axle shaft structures to maintain the axle shaft within the axle housing when the axle shaft/hub connectors are removed. Upon removal of such connectors, the hub rotates freely without imparting rotation to the axle shaft. Still further, an accessory spring may be provided for assisting in disengagement of the axle shaft flange from the hub.
Patent CA-2663410-A1 (CA)
Title: Systeme de rasage humide comprenant un adjuvant de rasage enrobe d'huile minerale
Inventor: KWIECIEN MICHAEL J
IPC: B26B21/44
Filed: 2007-09-06
Abstract: L'invention concerne un système de rasage humide comprenant un élément à lames et une partie d'engagement de la peau au voisinage dudit élément à lames, la partie d'engagement de la peau comprenant un composite d'adjuvant de rasage polymérique solide comprenant une partie exposée contenant un adjuvant de rasage soluble dans l'eau dispersé dans une matrice polymérique insoluble dans l'eau, l'adjuvant de rasage soluble dans l'eau étant enrobé d'huile minérale.
Patent CA-2663447-A1 (CA)
Title: Polymeric bone cement and methods of use thereof
Inventor: GLOBERMAN OREN
IPC: A61K6/884
Filed: 2007-09-11
Abstract: A bone cement comprising an acrylic polymer mixture which is formulated to have a relatively high viscosity for a relatively long window, due to distributions of molecular weights and/or sizes of acrylic beads.
Patent CA-2665258-A1 (CA)
Title: A power receptacle
Inventor: DE GROEN THOMAS DAVID
IPC: H01R24/76
Filed: 2007-10-05
Abstract: A power receptacle suitable for desktop use. The power receptacle has a casing (3) with a plurality of exterior walls. At least one socket (33, 35, 37) is accessible from the exterior of the casing. The socket(s) is/are configured to receive a power plug of a device to be powered which plug is in electrical connection with a power cord for the device. The casing may have walls and a cavity within the casing, with the cavity accessible from an exterior of the casing via an opening (7c). The cavity is configured to receive part of the power cord of the device. At least one exterior surface of the casing may be formed of an elastomeric material. A plurality of sockets (33, 35, 37) may be in an exterior wall of the casing, with each socket oriented in the wall on an angle relative to any adjacent socket.
Patent CA-2665284-A1 (CA)
Title: Particle comprising a matrix and a radical initiator
Inventor: BAAIJ JOHAN P
IPC: C08L21/00
Filed: 2007-09-29
Abstract: The invention pertains to a particle comprising a composition containing a matrix and a peroxide or azo radical initiator. The composition may in addition comprise a polymerizable multifunctional monomer containing at least two ethylenic bonds. The invention further relates to particle-elastomers comprising said composition, and skim products, tires, tire treads, and belts comprising these particle-elastomers.
Patent CA-2665395-A1 (CA)
Title: Small molecule intervention for obesity
Inventor: CHIN KHEW-VOON
IPC: A61K31/585
Filed: 2007-10-17
Abstract: Methods and compositions for activating PLTP gene expression include administering an effective amount of a limonoid.
Patent CA-2665417-A1 (CA)
Inventor: RADU CRSITIAN
IPC: G06F21/31
Filed: 2006-10-03
Abstract: A proxy authentication method and apparatus is described for use in user authentication, e.g. for payment transactions. The authentication is carried out before the transaction between a electronic, e.g. digital identification device and a person terminal. Verification information is entered at the personal terminal to authenticate the user and if this is successful a verification flag is set in the digital identification device. The status of this flag, or an encrypted version thereof can be used by a transaction terminal of evidence that the user has been authenticated without having to transmit any secret identification information to the transaction terminal.
Patent CA-2666050-A1 (CA)
Title: Dispositif de transport d'une substance muni d'un detecteur optique de fuite
Inventor: COUDRAY PAUL
IPC: G01M3/22
Filed: 2007-10-10
Abstract: L'invention concerne un dispositif de transport d'une substance, comprena nt : une première conduite (1) destinée à contenir la substance; une fibre o ptique (5) solidaire de la première conduite (5) et s'étendant le long de ce tte conduite, la fibre optique (5) présentant plusieurs organes de détection (71, 75) espacés sur sa longueur, chaque organe de détection présentant un spectre de réflexion distinct, variant en fonction de la présence de la subs tance à détecter; un dispositif de contrôle présentant une source lumineuse apte à émettre une lumière dans le spectre de réflexion de chaque organe de détection, un récepteur lumineux apte à détecter l'amplitude d'une lumière d ans le spectre de réflexion de chaque organe de détection, et un module d'an alyse apte à déterminer la présence d'une fuite de la substance en fonction de l'amplitude lumineuse fournie par le récepteur lumineux.
Patent CA-2666528-A1 (CA)
Title: Firearm flash suppressor
Inventor: HORTOBAGYI THOMAS
IPC: F41A21/34
Filed: 2009-05-21
Abstract: There is provided a flash suppressor for use with a firearm to attenuate muzzle flash. The flash suppressor can be used in conjunction with attachments, and provides mounting and alignment means therefore. In an embodiment, the flash suppressor comprises: a generally cylindrical body having a longitudinal axis, a muzzle end, and an exit end; a passage extending through the body and along the longitudinal axis; and a set of apertures. The passage includes: a mount portion for mounting the flash suppressor to the firearm muzzle; a transition portion; an intermediate portion; and a truncated conical portion having a diameter that increases toward the exit end. The transition portion joins the mount portion and the intermediate portion, and the intermediate portion joins the transition portion and the truncated conical portion. The apertures extend through the body of the flash suppressor and into the truncated conical portion, and channel propellant gases.
Patent CA-2667667-A1 (CA)
Title: Solid or aqueous alkaline preparation comprising a creatine component, process for the production thereof and the use thereof
Inventor: GASTNER THOMAS
IPC: A23L1/305
Filed: 2007-10-26
Abstract: A solid or aqueous alkaline preparation comprising a creatine component which comprises a buffer system which adjusts a pH of from 8.0 to 12.0 is described. The creatine is better protected with the aid of the buffer system from conversion into creatinine in the stomach. It has additionally emerged, surprisingly, that the novel formulations display a distinctly higher bioavailability and are thus taken up better by cells. Finally, the preparation of the invention has very good organoleptic properties, which in fact likewise could not be predicted. Owing to these particular advantages, the preparation of the invention is outstandingly suitable as dietary supplements, restoratives, medicinal products and feedstuffs.
Patent CA-2670223-A1 (CA)
Title: Depsipeptides and their therapeutic use
Inventor: GANESAN ARASU
IPC: A61K38/07
Filed: 2007-11-22
Abstract: A com ound of the eneral Structure (VII) or (VIII) including isoteres and pharmaceutically acceptable salts thereof, wherein R1, R2 (where X = -CONR6-), R3 and R7 are the same or different and each represents an amino-acid side chain moiety; R2 (where X = -CHZ-), R4 and R6 are the same or different and each represents hydrogen, C1-C6 alkyl, C2-C6 alkenyl, or C2-C6 alkynyl; K represents a linear or branched chain of carbon atoms and containing 1-10 atoms; L represents a moiety capable of chelating zinc in the active site of a histone deacetylase (HDAC) or of conversion to such a moiety in vivo (by hydrolysis or reduction, for example); M is a linear or branched chain of carbon or other atoms and containing 1-10 atoms, and capable of undergoing in vivo cleavage to give Structure (VII); and Z is a heteroatom bonded to the macrocycle by a single or double bond, and any other group bonded to Z is H or a protecting group.